Abel ML, Takahashi N, Peer C, Redon CE, et al. Targeting Replication Stress and Chemotherapy Resistance with a Combination of Sacituzumab Govitecan and Berzosertib: A Phase I Clinical Trial. Clin Cancer Res 2023;29:3603-3611.
PMID: 37227187